J B Haanen
J B Haanen
J Haanen
J Haanen
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma [0.03%]
肿瘤浸润淋巴细胞与溶瘤腺病毒(TILT-123)联合治疗后，一例黏膜黑色素瘤患者的长期完全缓解响应
Background: Despite significant advancements in the treatment of malignant melanoma, metastatic mucosal melanoma remains a therapeutic challenge due to its complex pathogenesis, distinct pathological characteristics, and ...